CAMDEN NATIONAL ($CAC) posted quarterly earnings results for Q4 2025 on Tuesday, January 27th. The company reported earnings of $1.33 per share, missing estimates of $1.33 by $0.00. The company also reported revenue of $68,050,000, beating estimates of $66,826,650 by $1,223,350.
You can see Quiver Quantitative's $CAC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CAMDEN NATIONAL Hedge Fund Activity
We have seen 75 institutional investors add shares of CAMDEN NATIONAL stock to their portfolio, and 77 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FRANKLIN RESOURCES INC added 113,221 shares (+7.8%) to their portfolio in Q3 2025, for an estimated $4,369,198
- ASSENAGON ASSET MANAGEMENT S.A. removed 75,072 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $3,256,623
- WELLINGTON MANAGEMENT GROUP LLP added 73,050 shares (+129.7%) to their portfolio in Q3 2025, for an estimated $2,818,999
- TRUEMARK INVESTMENTS, LLC removed 68,253 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $2,960,815
- FIRST TRUST ADVISORS LP added 50,716 shares (+451.4%) to their portfolio in Q3 2025, for an estimated $1,957,130
- UBS GROUP AG removed 48,533 shares (-55.0%) from their portfolio in Q3 2025, for an estimated $1,872,888
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 47,562 shares (-63.3%) from their portfolio in Q3 2025, for an estimated $1,835,417
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CAMDEN NATIONAL Price Targets
Multiple analysts have issued price targets for $CAC recently. We have seen 2 analysts offer price targets for $CAC in the last 6 months, with a median target of $44.5.
Here are some recent targets:
- Damon Delmonte from Keefe, Bruyette & Woods set a target price of $45.0 on 10/29/2025
- Matt Breese from Stephens & Co. set a target price of $44.0 on 08/06/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
